Quinn William P. bought 637 shares of Bolt Biotherapeutics, Inc. at $3.88 for $2.47k on Jun 5, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
President, CEO and CFO
President, CEO and CFO
Filed Sep 21, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$2,469.01Shares × reported price
Shares traded
637Common Stock
Price per share
$3.88Reported price. Read footnotes for ranges.
% of reported position traded
27.54%This security and ownership context
Holdings after
2,950Direct
Trade date
Jun 5, 2026Buy
Filed
Sep 21, 2026, 6:03 PM ET108-day reporting delay
Accession
0001193125-26-396890Code P · Transaction 227036
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 2,313 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Sep 16, 2026Sell1,889$3.77−$7,129.09Trade 227037
Sep 17, 2026Sell6,545$3.32−$21,718.27Trade 227038
Sep 18, 2026Sell9,132$3.24−$29,554.80Trade 227039
4 transaction rows in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 108 calendar days after the transaction date.

BOLT price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
BOLT · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +31%1w ago +31%1d ago +38%
Returns since7d −10%30d +7.3%90d180d1y

Footnotes in full

F1: These shares were acquired under the Issuer's Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(c). F2: Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.60 to $4.14. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3: Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.22 to $3.67. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. F4: Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.15 to $3.41. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.